Barclays
MGRM

Barclays’s Monogram Orthopaedics MGRM Stock Holding History

Barclays’s Portfolio MGRM Stock Details MGRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,380
Closed -$19.8K – 5507
2025
Q3 		$19.8K Buy
+3,380
New +$18.1K ﹤0.01% 4933
2025
Q2 		– Sell
-531
Closed -$1.56K – 5434
2025
Q1 		$1.56K Sell
531
-10,774
-95% -$28.5K ﹤0.01% 5014
2024
Q4 		$26.8K Buy
11,305
+408
+4% +$957 ﹤0.01% 4879
2024
Q3 		$28.9K Buy
+10,897
New +$28.4K ﹤0.01% 4846

Barclays's MGRM Position: Q4 2025 in Review

Barclays sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 3,380 shares — an estimated $19.8K sold.

Barclays first reported a position in MGRM in Q3 2024 and held it in 4 quarters. The position peaked at $28.9K in Q3 2024. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

  • Barclays reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 3,380 Monogram Orthopaedics shares in Q4 2025, an estimated $19.8K.
  • Barclays first reported a position in Monogram Orthopaedics in Q3 2024 and held it in 4 quarters.
  • Barclays's Monogram Orthopaedics position peaked at $28.9K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.